Abstract:ID 87555 Poster Board 494 Bioactive compounds sometimes possess unfavorable properties for drug development due to on-target, off-tissue mediated side effects or poor pharmacological properties. Activation of drug targets expressed in tissues not involved in therapeutic responses can limit medical application. One solution is to use analogue(s) or fragments of bioactive drugs that become activated only at sites of interest. Herein we describe the development of fragments of a peptidic GPCR ligand that can react to form a bioactive product upon exposure to a dimerizing agent that stimulates in situ assembly. To enhance specificity, we developed methods for the directed delivery of such a dimerizing agent to cell types of choice. We sought to apply this approach for activation of the parathyroid hormone receptor-1 (PTHR1), which regulates skeletal development and mineral ion homeostasis. The prototypical peptide agonist of PTHR1 (PTH 1-34 ) was separated into two constituent fragments (PTH 1-11 and PTH 12-34 ), each of which possesses little to no biological activity alone. In situ synthesis of conjugates that resemble PTH 1-34 was achieved through peptide template-induced dimerization and click (azide-alkyne) reactions between the fragment peptides PTH 1-11 and PTH 12-34. Dimerization is facilitated through the binding of nanobodies (Nbs) to peptide tags as described below. Nbs are single antigen recognition domains of heavy-chain only antibodies, which exhibit specificity and affinity for biological macromolecules comparable to conventional antibodies. Templated dimerization was achieved by fusing PTH fragments containing click chemistry handles to one of two Nbs that bind to short peptide epitopes. A heterodimeric peptide (HDP), comprised of the two distinct Nb-binding peptide epitopes, was used to bring fusions comprised of Nbs and PTH fragments with complementary click handles, into proximity. HDP-induced co-localization was designed to trigger the click reaction within the cellular medium at high dilution. Gel electrophoresis analysis of the kinetics of the reaction between azide- and alkyne-functionalized Nbs showed that HDP-mediated dimerization accelerated reaction kinetics. In the context of a cell-based assays, PTH fragment-click handle-Nb conjugates were weakly active alone or when added in tandem. The addition of HDP to the tandem mixture resulted in strong activation (via in situ ligand assembly) of PTHR1. We further demonstrate that dimeric peptide-induced in situ assembly can be achieved with cell-type specificity and high efficiency via Nb-based delivery of dimerizing agent. Altogether, this approach entails a new strategy for in situ synthesis of a bioactive agonist from its inactive fragment peptides. These results offer a path towards in situ assembly of bioactive molecules based on targeted delivery of dimerizing agents. These findings, coupled with the modular and programmable nature of our strategy, suggest the possibility of engineering similar approaches for the targeted synthesis of a diverse range of clinically relevant molecules in various in vitro and in vivo settings. This research was supported by the Intramural Research Program of the NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Engineering of therapeutic polypeptides through chemical synthesis: early lessons from human parathyroid hormone and analogues.

Chemistry As an Expanding Resource in Protein Science: Fully Synthetic and Fully Active Human Parathyroid Hormone‐Related Protein (1–141)

Through the looking glass--a new world of proteins enabled by chemical synthesis

Chemical Synthesis of Human Proteoforms and Application in Biomedicine

α-Amino acid N-thiocarboxyanhydrides: A novel synthetic approach toward poly(α-amino acid)s

Electrochemical Synthesis of Unnatural Amino Acids via Anodic Decarboxylation of N-Acetylamino Malonic Acid Derivatives

Chemical synthesis of peptides within the insulin superfamily

Recent advances in chemical protein synthesis: method developments and biological applications

Toward Homogeneous Erythropoietin: Application Of Metal-Free Dethiylation In The Chemical Synthesis Of The Ala79-Arg166 Glycopeptide Domain

Stereoselective synthesis of a phosphonate pThr mimetic via palladium-catalyzed γ-C(sp3)–H activation for peptide preparation

Chemoenzymatic synthesis of small molecule human therapeutics.

Automated Flow Peptide Synthesis Enables Engineering of Proteins with Stabilized Transient Binding Pockets

Synthesis of Unnatural Amino Acids Through Palladium-Catalyzed C(sp3)H Functionalization

Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform

The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations

Design, Synthesis and Catalytic Activity of Protein Containing Thiotyrosine as an Active Site Residue

Activation of PTH1 receptor using chimeric peptide templated in situ click reaction of nanobody conjugates

Design and Synthetic Strategies for Helical Peptides.

Novel protein science enabled by total chemical synthesis

Total Chemical Synthesis of Bovine Pancreatic Trypsin Inhibitor by Native Chemical Ligation.